These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 18412221)
21. The efficacy of photodynamic therapy combined with intravitreal triamcinolone acetonide (TA) for treatment of occult choroidal neovascularization secondary to age-related macular degeneration. Ho TC Retina; 2006; 26(6):714; author reply 715. PubMed ID: 16829825 [No Abstract] [Full Text] [Related]
22. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma. Battaglia Parodi M; Da Pozzo S; Toto L; Saviano S; Ravalico G Retina; 2001; 21(6):660-1. PubMed ID: 11756892 [No Abstract] [Full Text] [Related]
24. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks. Karadimas P; Bouzas EA Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772 [No Abstract] [Full Text] [Related]
25. Choroidal neovascularization after accidental macular damage by laser. Nehemy M; Torqueti-Costa L; Magalhães EP; Vasconcelos-Santos DV; Vasconcelos AJ Clin Exp Ophthalmol; 2005 Jun; 33(3):298-300. PubMed ID: 15932537 [TBL] [Abstract][Full Text] [Related]
26. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration. Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A Retina; 2006; 26(9):988-93. PubMed ID: 17151484 [TBL] [Abstract][Full Text] [Related]
27. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration. Pawlak D; Glacet-Bernard A; Papp M; Roquet W; Coscas G; Soubrane G Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153 [TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Ergun E; Tittl M; Stur M Arch Ophthalmol; 2004 Jan; 122(1):37-41. PubMed ID: 14718292 [TBL] [Abstract][Full Text] [Related]
29. Influence of treatment parameters on selectivity of verteporfin therapy. Michels S; Hansmann F; Geitzenauer W; Schmidt-Erfurth U Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):371-6. PubMed ID: 16384987 [TBL] [Abstract][Full Text] [Related]
36. Combined photodynamic therapy and intravitreal triamcinolone injection for choroidal neovascularization in Best disease. Nóbrega M; Bortolotto C; Farah M Can J Ophthalmol; 2007 Oct; 42(5):761-2. PubMed ID: 17891211 [No Abstract] [Full Text] [Related]
37. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498 [TBL] [Abstract][Full Text] [Related]
38. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216 [TBL] [Abstract][Full Text] [Related]
39. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin. Schmidt-Erfurth UM; Michels S Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383 [TBL] [Abstract][Full Text] [Related]
40. Macular injury by a military range finder. Roider J; Buesgen P; Hoerauf H; Schmidt-Erfurth U; Laqua H; Birngruber R Retina; 1999; 19(6):531-5. PubMed ID: 10606454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]